Hiroyuki Tanaka

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The aggregation of amyloid β protein (Aβ) is a key step in the pathogenesis of Alzheimer's disease (AD), and therefore inhibitory substances for Aβ aggregation may have preventive and/or therapeutic potential for AD. Here we report a novel microliter-scale high-throughput screening system for Aβ aggregation inhibitors based on fluorescence(More)
  • 1